{
"id":"mk19_b_hm_f24",
"number":24,
"bookId":"hm",
"legend":{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Algorithm to guide the diagnosis and initial management of patients with suspected heparin-induced thrombocytopenia (HIT)."
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Argatroban, bivalirudin, danaparoid, fondaparinux, rivaroxaban."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Most patients with a negative functional assay do not have HIT, but false-negative results are possible. Consider a diagnosis of HIT in select patients with a negative functional assay but a high-probability 4T score and a strongly positive immunoassay."
],
[
"Adapted with permission of Elsevier Science & Technology Journals, from Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2:3360-3392. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/30482768",
"target":"_blank"
},
"children":[
"PMID: 30482768"
]
},
". doi:10.1182/bloodadvances.2018024489. Permission conveyed through Copyright Clearance Center, Inc."
]
],
"imageInfo":{
"hash":"aff4c1774abf53117e6eaa1c345aa9f4",
"height":543,
"width":472,
"extension":"svg",
"vector":true
}
}